tiprankstipranks
Pfizer withdrawal of Oxbryta raises questions, sends Fulcrum stock higher
PremiumThe FlyPfizer withdrawal of Oxbryta raises questions, sends Fulcrum stock higher
2M ago
Leerink sees little impact to genetic medicines from Pfizer’s Oxbryta withdrawal
Premium
The Fly
Leerink sees little impact to genetic medicines from Pfizer’s Oxbryta withdrawal
2M ago
Fulcrum Therapeutics to reduce workforce from 80 to 51 full-time employees
Premium
The Fly
Fulcrum Therapeutics to reduce workforce from 80 to 51 full-time employees
2M ago
Moderna, Halliburton downgraded: Wall Street’s top analyst calls
PremiumThe FlyModerna, Halliburton downgraded: Wall Street’s top analyst calls
2M ago
Fulcrum Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
Fulcrum Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
2M ago
Fulcrum Therapeutics downgraded to Sector Perform from Outperform at RBC Capital
Premium
The Fly
Fulcrum Therapeutics downgraded to Sector Perform from Outperform at RBC Capital
2M ago
Fulcrum sinks 63% to $3.30 after facioscapulohumeral muscular dystrophy failure
PremiumThe FlyFulcrum sinks 63% to $3.30 after facioscapulohumeral muscular dystrophy failure
2M ago
Fulcrum Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald
Premium
The Fly
Fulcrum Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald
2M ago
Fulcrum Therapeutics suspends future losmapimod development after Phase 3 trial
Premium
The Fly
Fulcrum Therapeutics suspends future losmapimod development after Phase 3 trial
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100